Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Related structures:
AlphaFold database: Q4QBL9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 273 | 277 | PF00656 | 0.742 |
CLV_PCSK_KEX2_1 | 64 | 66 | PF00082 | 0.718 |
CLV_PCSK_PC1ET2_1 | 64 | 66 | PF00082 | 0.718 |
CLV_PCSK_SKI1_1 | 11 | 15 | PF00082 | 0.620 |
CLV_PCSK_SKI1_1 | 210 | 214 | PF00082 | 0.665 |
CLV_PCSK_SKI1_1 | 345 | 349 | PF00082 | 0.748 |
CLV_PCSK_SKI1_1 | 92 | 96 | PF00082 | 0.629 |
DEG_COP1_1 | 150 | 158 | PF00400 | 0.628 |
DEG_COP1_1 | 312 | 321 | PF00400 | 0.564 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.822 |
DOC_CKS1_1 | 259 | 264 | PF01111 | 0.697 |
DOC_CYCLIN_RxL_1 | 207 | 217 | PF00134 | 0.660 |
DOC_CYCLIN_RxL_1 | 8 | 16 | PF00134 | 0.681 |
DOC_CYCLIN_yCln2_LP_2 | 259 | 265 | PF00134 | 0.658 |
DOC_CYCLIN_yCln2_LP_2 | 284 | 290 | PF00134 | 0.777 |
DOC_CYCLIN_yCln2_LP_2 | 350 | 356 | PF00134 | 0.735 |
DOC_MAPK_gen_1 | 344 | 352 | PF00069 | 0.590 |
DOC_PP2B_LxvP_1 | 133 | 136 | PF13499 | 0.837 |
DOC_PP2B_LxvP_1 | 350 | 353 | PF13499 | 0.733 |
DOC_PP2B_PxIxI_1 | 109 | 115 | PF00149 | 0.702 |
DOC_USP7_MATH_1 | 128 | 132 | PF00917 | 0.801 |
DOC_USP7_MATH_1 | 221 | 225 | PF00917 | 0.542 |
DOC_USP7_MATH_1 | 244 | 248 | PF00917 | 0.754 |
DOC_USP7_MATH_1 | 252 | 256 | PF00917 | 0.654 |
DOC_USP7_MATH_1 | 30 | 34 | PF00917 | 0.647 |
DOC_USP7_MATH_1 | 306 | 310 | PF00917 | 0.789 |
DOC_USP7_MATH_1 | 378 | 382 | PF00917 | 0.741 |
DOC_USP7_MATH_1 | 47 | 51 | PF00917 | 0.509 |
DOC_USP7_MATH_1 | 52 | 56 | PF00917 | 0.608 |
DOC_USP7_UBL2_3 | 98 | 102 | PF12436 | 0.768 |
DOC_WW_Pin1_4 | 258 | 263 | PF00397 | 0.702 |
DOC_WW_Pin1_4 | 283 | 288 | PF00397 | 0.764 |
DOC_WW_Pin1_4 | 362 | 367 | PF00397 | 0.786 |
DOC_WW_Pin1_4 | 42 | 47 | PF00397 | 0.719 |
DOC_WW_Pin1_4 | 50 | 55 | PF00397 | 0.588 |
DOC_WW_Pin1_4 | 80 | 85 | PF00397 | 0.598 |
LIG_14-3-3_CanoR_1 | 3 | 13 | PF00244 | 0.660 |
LIG_14-3-3_CanoR_1 | 328 | 338 | PF00244 | 0.594 |
LIG_BIR_III_4 | 41 | 45 | PF00653 | 0.723 |
LIG_EH1_1 | 7 | 15 | PF00400 | 0.761 |
LIG_eIF4E_1 | 73 | 79 | PF01652 | 0.796 |
LIG_FHA_1 | 119 | 125 | PF00498 | 0.578 |
LIG_FHA_1 | 259 | 265 | PF00498 | 0.774 |
LIG_FHA_1 | 5 | 11 | PF00498 | 0.640 |
LIG_FHA_2 | 271 | 277 | PF00498 | 0.750 |
LIG_FHA_2 | 298 | 304 | PF00498 | 0.770 |
LIG_GBD_Chelix_1 | 382 | 390 | PF00786 | 0.588 |
LIG_MYND_1 | 137 | 141 | PF01753 | 0.770 |
LIG_NRP_CendR_1 | 388 | 391 | PF00754 | 0.700 |
LIG_Pex14_2 | 17 | 21 | PF04695 | 0.701 |
LIG_SH2_NCK_1 | 253 | 257 | PF00017 | 0.716 |
LIG_SH2_NCK_1 | 272 | 276 | PF00017 | 0.511 |
LIG_SH2_PTP2 | 111 | 114 | PF00017 | 0.785 |
LIG_SH2_SRC | 71 | 74 | PF00017 | 0.797 |
LIG_SH2_STAP1 | 253 | 257 | PF00017 | 0.712 |
LIG_SH2_STAP1 | 71 | 75 | PF00017 | 0.795 |
LIG_SH2_STAT5 | 111 | 114 | PF00017 | 0.785 |
LIG_SH2_STAT5 | 272 | 275 | PF00017 | 0.748 |
LIG_SUMO_SIM_anti_2 | 261 | 268 | PF11976 | 0.688 |
LIG_SUMO_SIM_par_1 | 111 | 117 | PF11976 | 0.785 |
LIG_SUMO_SIM_par_1 | 261 | 268 | PF11976 | 0.688 |
LIG_SUMO_SIM_par_1 | 286 | 292 | PF11976 | 0.793 |
LIG_TRAF2_1 | 247 | 250 | PF00917 | 0.529 |
LIG_TRAF2_1 | 300 | 303 | PF00917 | 0.772 |
MOD_CK1_1 | 129 | 135 | PF00069 | 0.848 |
MOD_CK1_1 | 150 | 156 | PF00069 | 0.707 |
MOD_CK1_1 | 50 | 56 | PF00069 | 0.586 |
MOD_CK2_1 | 244 | 250 | PF00069 | 0.640 |
MOD_CK2_1 | 291 | 297 | PF00069 | 0.826 |
MOD_CK2_1 | 378 | 384 | PF00069 | 0.741 |
MOD_Cter_Amidation | 96 | 99 | PF01082 | 0.700 |
MOD_GlcNHglycan | 106 | 109 | PF01048 | 0.762 |
MOD_GlcNHglycan | 127 | 131 | PF01048 | 0.800 |
MOD_GlcNHglycan | 156 | 159 | PF01048 | 0.733 |
MOD_GlcNHglycan | 163 | 166 | PF01048 | 0.588 |
MOD_GlcNHglycan | 223 | 226 | PF01048 | 0.554 |
MOD_GlcNHglycan | 254 | 257 | PF01048 | 0.775 |
MOD_GlcNHglycan | 302 | 307 | PF01048 | 0.856 |
MOD_GlcNHglycan | 308 | 311 | PF01048 | 0.757 |
MOD_GlcNHglycan | 319 | 322 | PF01048 | 0.529 |
MOD_GlcNHglycan | 331 | 334 | PF01048 | 0.505 |
MOD_GlcNHglycan | 41 | 45 | PF01048 | 0.798 |
MOD_GlcNHglycan | 49 | 52 | PF01048 | 0.619 |
MOD_GlcNHglycan | 54 | 57 | PF01048 | 0.531 |
MOD_GSK3_1 | 147 | 154 | PF00069 | 0.825 |
MOD_GSK3_1 | 298 | 305 | PF00069 | 0.818 |
MOD_GSK3_1 | 306 | 313 | PF00069 | 0.718 |
MOD_GSK3_1 | 324 | 331 | PF00069 | 0.536 |
MOD_GSK3_1 | 348 | 355 | PF00069 | 0.665 |
MOD_GSK3_1 | 80 | 87 | PF00069 | 0.684 |
MOD_NEK2_1 | 104 | 109 | PF00069 | 0.648 |
MOD_NEK2_1 | 147 | 152 | PF00069 | 0.812 |
MOD_NEK2_1 | 181 | 186 | PF00069 | 0.674 |
MOD_NEK2_1 | 79 | 84 | PF00069 | 0.752 |
MOD_OFUCOSY | 311 | 316 | PF10250 | 0.620 |
MOD_PIKK_1 | 245 | 251 | PF00454 | 0.525 |
MOD_PKA_1 | 345 | 351 | PF00069 | 0.710 |
MOD_PKA_1 | 98 | 104 | PF00069 | 0.497 |
MOD_Plk_1 | 147 | 153 | PF00069 | 0.735 |
MOD_ProDKin_1 | 258 | 264 | PF00069 | 0.698 |
MOD_ProDKin_1 | 283 | 289 | PF00069 | 0.767 |
MOD_ProDKin_1 | 362 | 368 | PF00069 | 0.790 |
MOD_ProDKin_1 | 42 | 48 | PF00069 | 0.720 |
MOD_ProDKin_1 | 50 | 56 | PF00069 | 0.585 |
MOD_ProDKin_1 | 80 | 86 | PF00069 | 0.596 |
MOD_SUMO_rev_2 | 292 | 300 | PF00179 | 0.636 |
TRG_ENDOCYTIC_2 | 111 | 114 | PF00928 | 0.785 |
TRG_ENDOCYTIC_2 | 59 | 62 | PF00928 | 0.679 |
TRG_NES_CRM1_1 | 9 | 20 | PF08389 | 0.516 |
TRG_Pf-PMV_PEXEL_1 | 11 | 15 | PF00026 | 0.752 |
TRG_Pf-PMV_PEXEL_1 | 202 | 206 | PF00026 | 0.794 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8ICA2 | Leishmania donovani | 87% | 100% |
A4HCG5 | Leishmania braziliensis | 68% | 100% |
E9AGZ8 | Leishmania infantum | 87% | 100% |
E9AVW0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 82% | 100% |